D. Horwell, et al., Eur. J. Med. Chem., (1990) 25, 53-60. |
D. Horwell, et al., J. Med. Chem., 1991, 34, 404-414. |
Chemical Abstracts, vol. 109, 1988, p. 666, 109:670g. |
Chemical Abstracts, vol. 113, 1990, p. 715, 113:132771p. |
Copending application U.S. Ser. No. 07/576,308 filed Aug. 31, 1990. |
Copending application U.S. Ser. No. 07/576,628 filed Aug. 31, 1990. |
Copending application U.S. Ser. No. 07/576,296 filed Aug. 31, 1990. |
Copending application U.S. Ser. No. 07/576,024 filed Aug. 31, 1990. |
Copending application U.S. Ser. No. 07/576,297 filed Aug. 31, 1990. |
Brain Research, 288 (1983) 199-211, G. W. Roberts et al., "Peptides, the Limbic Lobe and Schizophrenia". |
Brain Research, 406 (1987) 130-135, B. A. MacVicar et al., "Inhibition of synantic transmission in the hippocampus by . . . ". |
British Medical Bulletin (1982) vol. 38, No. 3, 253-258, Dockray, "Physiology of Cholecystokinin in Brain and Gut". |
Cancer Research 46, 1612-1616, Apr. 1986, P. Singh et al., "Role of Gastrin and Gastrin Receptors on the Growth of a . . . ". |
CCK in the Nervous System, Chapter 7, pp. 110-127, M. J. Sheehan et al., 1984 "Central Actions of Cholecystokinin: Behavioural and Release Studies". |
Comprehensive Medicinal Chemistry, v.5, 1990, 122-133, 23.4.3, "Prodrugs". |
Drug Delivery Systems, Chapter 4, pp. 112-176, V. J. Stella et al., "Prodrugs: the control of drug delivery via bioreversible . . . " 1985. |
Drugs, 29: 455-473 (1985), V.J. Stella et al., "Prodrugs, Do they have Advantages in Clinical Practice?". |
Drugs of the Future, v. 15, No. 4, 1990, pp. 361-368, E. Palomino, "Delivery of Drugs Through Dihydropyridine Carriers". |
Gastroenterology, 1988:95: 1541-1548, J. Palmer Smith et al., "Effects of Gastrin, Proglumide, and Somatostatin on Growth . . . ". |
Gastrointestinal Hormones, 1980, Chapter 7, pp. 169-221, Viktor Mutt, "Cholecystokinin: Isolation, Structure, and Functions". |
Gastrointestinal Hormones, 1980, on Chapter 22, pp. 507-527, L.R. Johnson, "Effect of Gastrointestinal Hormones on Growth of Gastrointestinal Tiss:". |
Gastrointestinal Hormones, 1980, Chapter 23, 529-564, S. J. Konturek, "Gastrointestinal Hormones and Gastric Secretion". |
Gastrointestinal Hormones, 1980, Chapter 30, 729-739, Fl. Stadil, "Gastrinomas". |
Life Sciences, v. 27, pp. 355-368, John E. Morley, "The Neuroendocrine Control of Appetite: The Role of the Endogenous Opiates . . . " 1980. |
Journal of Medicinal Chemistry, v. 23, No. 12, Dec. 1980, 1275-1281 V. J. Stella, "Prodrugs and Site-Specific Drug Delivery". |
Journal of Medicinal Chemistry,v. 32, 1989, 1774-1781, E. Pop et al., "Brain-Specific Chemical Delivery Systems for B-Lactam Antibiotics . . . ". |
Journal of Medicinal Chemistry, v. 32, 1989, 1782-1788, W. Wu et al., "Brain-Specific Chemical Delivery Systems for B-Lactam Antibiotics . . . ". |
Journal of Medicinal Chemistry, v. 32, 1989, 1789-1795, E. Pop et al., "Chemical Delivery Systems for Some Penicillinase-Resistant . . . ". |
Journal of Medicinal Chemistry, v. 33, 1990, 344-347, A. English et al "Orally effective Acid Prodrugs of the B-Lactomase Inhibitor Sulbactam". |
Medicinal Research Reviews, v. 4, No. 4, (1984), 449-469, N. Boder, "Soft Drugs: Principles and Methods for the Design of Safe Drugs". |
Journal of Neurochemistry, v. 32, pp. 1339-1341, 1979, "Immunochemical evidence of cholecystokinin tetrapeptides in hog brain". |
Neuropharmacology, v. 26, No. 4, pp. 289-300, 1987, R. G. Hill et al., "Antinociceptive Action of Cholecystokinin Octapeptide (CCK 8) . . . ". |
Journal of Neuroscience, Mar. 1988, 8(3): 988-1000, H. Demeulemeester et al., "Heterogeneity of GABAergic Cells in Cat Visual Cortex". |
Neuroscience, v. 19, No. 1, pp. 181-192, 1986, S. Totterdell et al., "Cholecystokinin-Immunoreactive Boutons in Synaptic Contact . . . ". |
Peptides, v. 4, pp. 749-753, 1983, L. H. Schneider et al., "CCK-8 Modulation of Mesolimbic Dopamine: Antagonism of Amphetamine . . . ". |
The Pharmacological Basis of Therapeuctics, 7th ed., 1985, Chapter 17, S. Harvey, "Hypnotics and Sedatives". |
Pharmacology Biochemistry& Behaviour, v. 30, pp. 309-317, 1988, F. Weiss et al., "Opposite Actions of CCK-8 on Amphetamine-Induced . . . ". |
Proc. Natl. Acad. Sci., v. 87, pp.6728-6732, Sep. 1990, J. Hughes et al "Development of a class of selective cholecystokinin type B receptor . . . ". |
Regulatory Peptides, 14 (1986) 277-291, R. R. Schick et al., "Intracerebroventricular injections of cholecystokinin octapeptide . . . ". |
Science, v. 206, 26 Oct. 1979, pp. 471-473, "Cholecystokinin Octapeptide: Continuous Picomole Injections into the Cerebral . . . ". |
Trends in Pharmacological Sciences, v. 3, Feb. 1982, pp. 53-56, N. Bodor, "Designing Safer Drugs based on the Soft Drug Approach". |
Trends in Pharmacological Sciences, v. 11, Jul. 1990, pp. 271-273, "Cholecystokinin and Anxiety". |